Bactiguard Holding AB (publ) BACTI-B.ST
Nasdaq Tukholma · Terveydenhuolto · Medical Devices
Pidä tämä osake seurantalistallasi ja aseta sähköposti-ilmoitukset kursseista, raporteista ja tärkeistä tiedotteista, kun niitä on saatavilla.
Terveydenhuolto, Nasdaq Tukholma
126 osaketta toimialalla. Bactiguard Holding on sijalla 43/115.
Toimialan järjestys vertaa osakkeita vain keskenään: kunkin osakkeen laatu-, arvo- ja momentumpisteet muutetaan sen sijaksi toimialan osakkeiden joukossa välillä 0 (heikoin) – 100 (paras), ja järjestys perustuu niiden keskiarvoon. Kirjaudu lisätäksesi nousuvaran tavoitehintaan järjestykseen.
Laatu ja arvo
Ylöspäin on korkeampi laatu, oikealle halvempi. Kuplan koko on markkina-arvo.
Toimialan järjestys
Osien keskiarvo, 0–100.
Kaikki toimialan osakkeet
| # | Yhtiö | Toimialapisteet | Laatu | Arvo | Momentum | Nousuvara tavoitehintaan | P/E | ROE | Osinkotuotto | 1 vuosi | Ohjeistus saavutettu | Markkina-arvo (milj.) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sprint Bioscience SPRINT.ST | 94 | 94 | 63 | 90 | 🔒 | 4,6 | 77,0% | 0,0% | +468,2% | – | 422 |
| 2 | Xbrane Biopharma XBRANE.ST | 92 | 94 | 73 | 74 | 🔒 | 2,1 | 22,7% | 0,0% | +20,4% | – | 262 |
| 3 | Nolato NOLA-B.ST | 79 | 71 | 62 | 60 | 🔒 | 17,6 | 14,1% | 3,3% | −13,4% | – | 13 711 |
| 4 | Attendo ATT.ST | 78 | 54 | 51 | 93 | 🔒 | 23,4 | 14,9% | 0,7% | +64,1% | – | 19 062 |
| 5 | Ambea AMBEA.ST | 78 | 51 | 51 | 95 | 🔒 | 23,7 | 12,8% | 1,4% | +56,3% | – | 15 747 |
| 6 | Arjo ARJO-B.ST | 76 | 46 | 60 | 82 | 🔒 | 29,9 | 4,5% | 2,6% | +23,2% | – | 9 991 |
| 7 | Synsam SYNSAM.ST | 75 | 66 | 62 | 57 | 🔒 | 18,4 | 18,6% | 3,1% | −2,5% | – | 8 355 |
| 8 | Saniona SANION.ST | 75 | 95 | 67 | 18 | 🔒 | 5,4 | 44,8% | 0,0% | −31,3% | – | 1 546 |
| 9 | Getinge GETI-B.ST | 75 | 59 | 44 | 88 | 🔒 | 33,5 | 7,7% | 1,7% | +28,5% | – | 75 664 |
| 10 | Arcoma ARCOMA.ST | 74 | 70 | 52 | 66 | 🔒 | 24,2 | 6,7% | 0,0% | +6,2% | – | 122 |
| 11 | CellaVision CEVI.ST | 73 | 84 | 35 | 83 | 🔒 | 31,0 | 17,2% | 1,4% | +14,7% | – | 4 746 |
| 12 | AstraZeneca AZN.ST | 71 | 75 | 38 | 75 | 🔒 | 28,2 | 21,0% | 1,7% | +18,0% | – | 2 851 073 |
| 13 | BioGaia BIOG-B.ST | 70 | 90 | 32 | 75 | 🔒 | 37,1 | 25,3% | 3,3% | +24,8% | – | 12 352 |
| 14 | Cantargia CANTA.ST | 69 | 94 | 71 | 9 | 🔒 | 2,7 | 55,3% | 0,0% | −51,1% | – | 399 |
| 15 | Elekta EKTA-B.ST | 69 | 31 | 47 | 84 | 🔒 | – | −7,3% | 4,0% | +36,5% | – | 23 212 |
| 16 | Mendus IMMU.ST | 69 | – | 59 | 44 | 🔒 | – | −19,4% | 0,0% | −27,6% | – | 328 |
| 17 | RaySearch Laboratories RAY-B.ST | 68 | 82 | 46 | 43 | 🔒 | 26,6 | 23,1% | 2,3% | −17,8% | – | 6 058 |
| 18 | Orexo ORX.ST | 68 | 100 | 77 | 2 | 🔒 | 0,1 | 130,3% | 0,0% | −94,9% | – | 47 |
| 19 | Perpetua Medical PERP-B.ST | 68 | 81 | 81 | 10 | 🔒 | 3,0 | 12,4% | 0,0% | −64,3% | – | 7 |
| 20 | BioArctic BIOA-B.ST | 68 | 91 | 32 | 62 | 🔒 | 26,6 | 52,0% | 0,7% | +8,7% | – | 27 231 |
| 21 | Surgical Science Sweden SUS.ST | 66 | 70 | 41 | 56 | 🔒 | 47,1 | 1,6% | 0,0% | −26,1% | – | 3 146 |
| 22 | Apotea APOTEA.ST | 66 | 69 | 25 | 88 | 🔒 | 47,5 | 27,1% | 0,6% | +30,7% | – | 10 855 |
| 23 | Stille STIL.ST | 65 | 69 | 26 | 83 | 🔒 | 40,9 | 7,9% | 0,0% | +43,6% | – | 2 278 |
| 24 | Moberg Pharma MOB.ST | 65 | 23 | 55 | 73 | 🔒 | – | −4,1% | 0,0% | +33,5% | – | 489 |
| 25 | AddLife ALIF-B.ST | 65 | 56 | 36 | 73 | 🔒 | 40,1 | 10,3% | 0,8% | −6,5% | – | 22 435 |
| 26 | Medicover MCOV-B.ST | 64 | 53 | 33 | 81 | 🔒 | 47,2 | 14,5% | 0,9% | +9,8% | – | 40 311 |
| 27 | Isofol Medical ISOFOL.ST | 63 | – | 28 | 89 | 🔒 | – | −50,2% | 0,0% | +105,8% | – | 397 |
| 28 | Scandinavian Real Heart AB (Publ) HEART.ST | 63 | – | 46 | 58 | 🔒 | – | −56,8% | 0,0% | +11,7% | – | 84 |
| 29 | Carasent CARA.ST | 63 | 71 | 29 | 67 | 🔒 | 50,6 | 4,3% | 0,0% | −6,6% | – | 1 753 |
| 30 | BrainCool BRAIN.ST | 63 | 19 | 37 | 92 | 🔒 | – | −21,1% | 0,0% | +87,1% | – | 423 |
| 31 | Camurus CAMX.ST | 62 | 90 | 14 | 85 | 🔒 | 59,0 | 17,4% | 0,0% | +19,6% | – | 43 422 |
| 32 | Vimian Group VIMIAN.ST | 62 | 56 | 24 | 89 | 🔒 | 64,1 | 4,5% | 0,0% | +40,8% | – | 22 130 |
| 33 | IDL Diagnostics IDLDX.ST | 62 | 28 | 60 | 42 | 🔒 | – | −8,2% | 0,0% | −12,2% | – | 76 |
| 34 | Sectra SECT-B.ST | 61 | 90 | 19 | 80 | 🔒 | 112,0 | 26,4% | 0,7% | +11,3% | – | 63 118 |
| 35 | BICO Group BICO.ST | 61 | 14 | 50 | 80 | 🔒 | – | −62,3% | 0,0% | +1,9% | – | 1 718 |
| 36 | Alvotech ALVO-SDB.ST | 61 | 40 | 36 | 73 | 🔒 | 53,9 | – | 0,0% | +0,0% | – | 14 883 |
| 37 | Bonesupport Holding BONEX.ST | 60 | 84 | 10 | 85 | 🔒 | 148,5 | 16,4% | 0,0% | +53,7% | – | 21 114 |
| 38 | MedCap MCAP.ST | 60 | 75 | 23 | 68 | 🔒 | 38,3 | 15,1% | 0,0% | −3,4% | – | 8 426 |
| 39 | Sedana Medical SEDANA.ST | 59 | 28 | 49 | 52 | 🔒 | – | −6,6% | 0,0% | −5,5% | – | 947 |
| 40 | Vitrolife VITR.ST | 58 | 12 | 56 | 58 | 🔒 | – | −63,5% | 0,9% | −15,2% | – | 16 267 |
| 41 | Vivesto VIVE.ST | 58 | – | 63 | 14 | 🔒 | – | −27,4% | 0,0% | −65,3% | – | 43 |
| 42 | Swedish Orphan Biovitrum SOBI.ST | 56 | 49 | 20 | 89 | 🔒 | 360,3 | 1,3% | 0,0% | +49,9% | – | 172 208 |
| 43 | Bactiguard Holding BACTI-B.ST | 56 | 33 | 37 | 53 | 🔒 | – | −2,5% | 0,0% | −4,3% | – | 543 |
| 44 | Integrum INTEG-B.ST | 56 | 20 | 46 | 53 | 🔒 | – | −26,9% | 0,0% | −3,2% | – | 215 |
| 45 | Flerie FLERIE.ST | 56 | – | 64 | 11 | 🔒 | – | −22,4% | 0,0% | −63,5% | – | 1 133 |
| 46 | Genovis AB (publ.) GENO.ST | 55 | 81 | 17 | 66 | 🔒 | 59,3 | 8,6% | 0,0% | −6,4% | – | 1 394 |
| 47 | Paxman PAX.ST | 55 | 54 | 21 | 77 | 🔒 | – | −4,1% | 0,0% | −5,6% | – | 1 455 |
| 48 | Mentice MNTC.ST | 54 | 49 | 22 | 81 | 🔒 | – | −23,4% | 0,0% | +60,1% | – | 423 |
| 49 | Boule Diagnostics BOUL.ST | 54 | 31 | 69 | 6 | 🔒 | – | −2,2% | 0,0% | −80,9% | – | 47 |
| 50 | C-Rad CRAD-B.ST | 54 | 66 | 33 | 34 | 🔒 | 76,2 | 3,0% | 0,4% | −27,1% | – | 797 |
| 51 | Asker Healthcare Group ASKER.ST | 52 | 46 | 29 | 55 | 🔒 | 59,2 | 7,5% | 0,5% | −14,2% | – | 29 149 |
| 52 | Dynavox Group DYVOX.ST | 52 | 68 | 28 | 40 | 🔒 | 45,1 | 27,5% | 0,7% | −24,7% | – | 7 473 |
| 53 | Nanexa NANEXA.ST | 52 | 50 | 12 | 88 | 🔒 | – | −11,2% | 0,0% | +461,7% | – | 1 616 |
| 54 | ScandiDos SDOS.ST | 52 | 31 | 56 | 14 | 🔒 | – | −8,2% | 0,0% | −52,4% | – | 29 |
| 55 | SenzaGen SENZA.ST | 51 | 26 | 40 | 42 | 🔒 | – | −14,9% | 0,0% | −23,8% | – | 146 |
| 56 | Alzinova ALZ.ST | 51 | – | 64 | 6 | 🔒 | – | −21,5% | 0,0% | −76,6% | – | 36 |
| 57 | Physitrack PTRK.ST | 50 | 12 | 43 | 49 | 🔒 | – | −87,2% | 0,0% | −28,7% | – | 172 |
| 58 | Iconovo ICO.ST | 50 | 10 | 60 | 30 | 🔒 | – | −36,8% | 0,0% | −40,3% | – | 56 |
| 59 | SpectraCure SPEC.ST | 49 | – | 66 | 2 | 🔒 | – | −59,9% | 0,0% | −92,2% | – | 8 |
| 60 | Infant Bacterial Therapeutics IBT-B.ST | 49 | – | 19 | 83 | 🔒 | – | −61,9% | 0,0% | +26,7% | – | 991 |
| 61 | Intervacc IVACC.ST | 49 | 14 | 51 | 32 | 🔒 | – | −29,4% | 0,0% | −19,5% | – | 265 |
| 62 | Ortoma ORT-B.ST | 48 | 25 | 34 | 43 | 🔒 | – | −13,5% | 0,0% | −44,3% | – | 400 |
| 63 | BioInvent International BINV.ST | 48 | 12 | 64 | 10 | 🔒 | – | −59,7% | 0,0% | −92,5% | – | 164 |
| 64 | Neola Medical NEOLA.ST | 48 | – | 60 | 9 | 🔒 | – | −14,5% | 0,0% | −71,4% | – | 39 |
| 65 | Xvivo Perfusion XVIVO.ST | 46 | 62 | 18 | 45 | 🔒 | 247,2 | 1,2% | 0,0% | +11,5% | – | 6 221 |
| 66 | NextCell Pharma NXTCL.ST | 46 | 8 | 58 | 27 | 🔒 | – | −77,8% | 0,0% | −67,3% | – | 31 |
| 67 | Cinclus Pharma Holding CINPHA.ST | 46 | 12 | 43 | 34 | 🔒 | – | −49,8% | 0,0% | −31,1% | – | 562 |
| 68 | Modus Therapeutics Holding MODTX.ST | 45 | – | 38 | 25 | 🔒 | – | −204,4% | 0,0% | −59,3% | – | 19 |
| 69 | Xspray Pharma XSPRAY.ST | 44 | – | 55 | 10 | 🔒 | – | −28,3% | 0,0% | −56,6% | – | 464 |
| 70 | AlzeCure Pharma ALZCUR.ST | 44 | – | 17 | 81 | 🔒 | – | −144,8% | 0,0% | +187,3% | – | 803 |
| 71 | Fluicell FLUI.ST | 44 | 11 | 30 | 66 | 🔒 | – | −76,4% | 0,0% | +118,8% | – | 38 |
| 72 | Enzymatica ENZY.ST | 44 | 15 | 25 | 61 | 🔒 | – | −41,8% | 0,0% | +26,3% | – | 595 |
| 73 | OssDsign OSSD.ST | 43 | 24 | 45 | 13 | 🔒 | – | −16,4% | 0,0% | −66,1% | – | 419 |
| 74 | Active Biotech ACTI.ST | 43 | – | 42 | 16 | 🔒 | – | −67,1% | 0,0% | −44,6% | – | 95 |
| 75 | Promimic PRO.ST | 42 | 26 | 35 | 23 | 🔒 | – | −14,8% | 0,0% | −40,2% | – | 156 |
| 76 | Nosa Plugs NOSA.ST | 42 | 23 | 35 | 26 | 🔒 | – | −19,6% | 0,0% | −41,0% | – | 111 |
| 77 | Senzime SEZI.ST | 42 | 14 | 42 | 23 | 🔒 | – | −45,1% | 0,0% | −40,4% | – | 527 |
| 78 | Q-linea QLINEA.ST | 42 | 9 | 55 | 18 | 🔒 | – | −54,0% | 0,0% | −46,5% | – | 256 |
| 79 | Ascelia Pharma ACE.ST | 42 | – | 56 | 4 | 🔒 | – | −76,7% | 0,0% | −81,9% | – | 71 |
| 80 | Magle Chemoswed Holding MAGLE.ST | 42 | 11 | 66 | 1 | 🔒 | – | −84,0% | 0,0% | −98,5% | – | 6 |
| 81 | S2Medical S2M.ST | 42 | 11 | 61 | 7 | 🔒 | – | −102,2% | 0,0% | −69,0% | – | 4 |
| 82 | Egetis Therapeutics EGTX.ST | 41 | 6 | 18 | 97 | 🔒 | – | −101,2% | 0,0% | +76,2% | – | 4 394 |
| 83 | Devyser Diagnostics DVYSR.ST | 40 | 52 | 24 | 22 | 🔒 | – | −2,4% | 0,0% | −47,7% | – | 1 079 |
| 84 | Biovica International BIOVIC-B.ST | 39 | 8 | 49 | 24 | 🔒 | – | −80,9% | 0,0% | −36,4% | – | 91 |
| 85 | Vicore Pharma Holding VICO.ST | 39 | 9 | 35 | 42 | 🔒 | – | −43,6% | 0,0% | −7,1% | – | 2 877 |
| 86 | Corline Biomedical CLBIO.ST | 39 | 18 | 30 | 29 | 🔒 | – | −15,7% | 0,0% | −34,6% | – | 332 |
| 87 | Episurf Medical EPIS-B.ST | 39 | 6 | 40 | 41 | 🔒 | – | −122,5% | 0,0% | +83,8% | – | 92 |
| 88 | Ortivus ORTI-B.ST | 38 | 15 | 26 | 40 | 🔒 | – | −97,6% | 0,0% | −6,6% | – | 101 |
| 89 | AcouSort ACOU.ST | 38 | 10 | 28 | 49 | 🔒 | – | −74,6% | 0,0% | +11,6% | – | 65 |
| 90 | Initiator Pharma INIT.ST | 38 | – | 30 | 24 | 🔒 | – | −46,3% | 0,0% | −28,5% | – | 149 |
| 91 | Medivir MVIR.ST | 37 | 8 | 30 | 43 | 🔒 | – | −60,8% | 0,0% | +133,5% | – | 538 |
| 92 | EQL Pharma EQL.ST | 36 | 40 | 26 | 13 | 🔒 | 61,1 | 4,7% | 0,0% | −57,7% | – | 766 |
| 93 | Clinical Laserthermia Systems CLS-B.ST | 36 | 11 | 53 | 4 | 🔒 | – | −59,7% | 0,0% | −79,4% | – | 57 |
| 94 | ExpreS2ion Biotech Holding EXPRS2.ST | 36 | 5 | 64 | 2 | 🔒 | – | −106,7% | 0,0% | −94,4% | – | 9 |
| 95 | Spago Nanomedical SPAGO.ST | 35 | 5 | 54 | 13 | 🔒 | – | −86,4% | 0,0% | −75,1% | – | 24 |
| 96 | SynAct Pharma SYNACT.ST | 34 | – | 25 | 32 | 🔒 | – | −65,1% | 0,0% | −33,3% | – | 815 |
| 97 | IRLAB Therapeutics IRLAB-A.ST | 33 | 5 | 23 | 66 | 🔒 | – | −358,1% | 0,0% | −14,9% | – | 178 |
| 98 | Cereno Scientific CRNO-B.ST | 32 | – | 39 | 7 | 🔒 | – | −46,6% | 0,0% | −77,9% | – | 507 |
| 99 | Annexin Pharmaceuticals ANNX.ST | 32 | – | 35 | 10 | 🔒 | – | −148,0% | 0,0% | −66,5% | – | 64 |
| 100 | Immunovia IMMNOV.ST | 32 | 1 | 62 | 3 | 🔒 | – | −225,3% | 0,0% | −88,0% | – | 25 |
| 101 | Nanologica NICA.ST | 32 | 5 | 57 | 3 | 🔒 | – | −226,5% | 0,0% | −86,9% | – | 15 |
| 102 | FluoGuide FLUO.ST | 32 | – | 22 | 34 | 🔒 | – | −72,4% | 0,0% | −27,3% | – | 497 |
| 103 | Ortivus ORTI-A.ST | 31 | 15 | 22 | 26 | 🔒 | – | −97,6% | 0,0% | −34,5% | – | 148 |
| 104 | Pila Pharma PILA.ST | 31 | 5 | 26 | 47 | 🔒 | – | −116,1% | 0,0% | −27,0% | – | 67 |
| 105 | Prostatype Genomics PROGEN.ST | 29 | 2 | 58 | 2 | 🔒 | – | −167,8% | 0,0% | −83,0% | – | 15 |
| 106 | Dicot Pharma DICOT.ST | 24 | – | 22 | 19 | 🔒 | – | −109,4% | 0,0% | −53,5% | – | 477 |
| 107 | Elicera Therapeutics ELIC.ST | 23 | – | 23 | 14 | 🔒 | – | −74,5% | 0,0% | −57,4% | – | 130 |
| 108 | Acarix ACARIX.ST | 22 | 5 | 24 | 23 | 🔒 | – | −126,0% | 0,0% | −37,8% | – | 193 |
| 109 | Alligator Bioscience ATORX.ST | 22 | 1 | 48 | 0 | 🔒 | – | −748,7% | 0,0% | −99,5% | – | 7 |
| 110 | OncoZenge ONCOZ.ST | 20 | 4 | 25 | 16 | 🔒 | – | −188,0% | 0,0% | −39,9% | – | 40 |
| 111 | Neem's Hill NEEMS-B.ST | 16 | 9 | 17 | 13 | 🔒 | – | −252,9% | 0,0% | −61,6% | – | 55 |
| 112 | iZafe Group IZAFE-B.ST | 15 | 6 | 21 | 11 | 🔒 | – | −142,7% | 0,0% | −67,3% | – | 83 |
| 113 | Gabather GABA.ST | 15 | – | 18 | 13 | 🔒 | – | −702,7% | 0,0% | −49,0% | – | 9 |
| 114 | Luxbright LXB.ST | 12 | 10 | 16 | 3 | 🔒 | – | −72,4% | 0,0% | −90,6% | – | 893 |
| 115 | SciBase Holding SCIB.ST | 11 | 5 | 20 | 9 | 🔒 | – | −1 307,8% | 0,0% | −56,1% | – | 58 |
| – | Hansa Biopharma HNSA.ST | – | – | – | 74 | 🔒 | – | – | 0,0% | +29,8% | – | 3 936 |
| – | Oncopeptides ONCO.ST | – | – | – | 23 | 🔒 | – | – | 0,0% | −69,9% | – | 478 |
| – | Klaria Pharma Holding AB (publ.) KLAR.ST | – | – | – | 33 | 🔒 | – | – | 0,0% | +1,8% | – | 129 |
| – | Xintela XINT.ST | – | – | – | 11 | 🔒 | – | – | 0,0% | −66,5% | – | 118 |
| – | Simris Group AB (PUBL) SIMRIS-B.ST | – | – | – | 66 | 🔒 | – | – | 0,0% | +26,6% | – | 98 |
| – | Enorama Pharma ERMA.ST | – | – | – | 36 | 🔒 | – | – | 0,0% | −70,9% | – | 60 |
| – | Disruptive Pharma DPHA.ST | – | – | – | – | 🔒 | – | – | 0,0% | – | – | 43 |
| – | Aino Health AINO.ST | – | – | – | 66 | 🔒 | – | – | 0,0% | +6,4% | – | 37 |
| – | Qlife Holding QLIFE.ST | – | – | – | 16 | 🔒 | – | – | 0,0% | −55,3% | – | 15 |
| – | Diamyd Medical DMYD-B.ST | – | – | – | 2 | 🔒 | – | −60,6% | 0,0% | −90,6% | – | – |
| – | Newbury Pharmaceuticals NEWBRY.ST | – | – | – | 42 | 🔒 | – | – | 0,0% | −24,1% | – | – |
Lajittele napsauttamalla otsikkoa. Markkina-arvo miljoonina (SEK). Ei sijoitusneuvontaa. Vertaa osakekursseja →
Ei sijoitusneuvontaa. Luvuissa voi olla tietolähteen virheitä.